Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria

Drug Design, Development and Therapy

Volumn 11, Issue , 2017, Pages 939-946

  Wu, Xiaozhe ^a   Li, Zhan ^a   Li, Xiaolu ^b,c   Tian, Yaomei ^a   Fan, Yingzi ^a   Yu, Chaoheng ^a   Zhou, Bailing ^a   Liu, Yi ^d   Xiang, Rong ^e   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Chinese Medicine Sciences   (China)

^c THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^d Sichuan Center for Disease Control and Prevention ^*  (China)

^e NANKAI UNIVERSITY   (China)

Author keywords

Antimicrobial peptide; Drug synergy; Resistant bacteria

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIMICROBIAL PEPTIDE CLS001; ANTIMICROBIAL PEPTIDE DP7; AZITHROMYCIN; GENTAMICIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG POTENTIATION; ERMA GENE; ERMB GENE; ERMC GENE; ESCHERICHIA COLI; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEFA GENE; MINIMUM INHIBITORY CONCENTRATION; MSRA GENE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85016162024     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S107195     Document Type: Article

References (31)

1. Fuchs PC, Barry AL, Brown SD. In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob Agents Chemother. 1998;42(5):1213-1216.
2. Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol. 2014;12(7):465-478.
3. Makobongo MO, Gancz H, Carpenter BM, McDaniel DP, Merrell DS. The oligo-acyl lysyl antimicrobial peptide C(1)(2)K-2beta(1)(2) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Antimicrob Agents Chemother. 2012;56(1):378-390.
4. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother. 1999;43(4):782-788.
5. Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother. 2013;68(10):2286-2290.
6. Park Y, Kim HJ, Hahm KS. Antibacterial synergism of novel antibiotic peptides with chloramphenicol. Biochem Biophys Res Commun. 2004;321(1):109-115.
7. Giacometti A, Cirioni O, Kamysz W, et al. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Int J Antimicrob Agents. 2005;26(3):235-240.
8. Cirioni O, Silvestri C, Ghiselli R, et al. Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. J Antimicrob Chemother. 2008;62(6):1332-1338.
9. Dosler S, Karaaslan E. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides. 2014;62:32-37.
10. Dosler S, Karaaslan E, Alev Gerceker A. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria. J Chemother. Epub 2015 Mar 24.
11. Reffuveille F, de la Fuente-Nunez C, Mansour S, Hancock RE. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother. 2014;58(9):5363-5371.
12. de la Fuente-Nunez C, Reffuveille F, Mansour SC, et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol. 2015;22(2):196-205.
13. de la Fuente-Nunez C, Cardoso MH, de Souza Candido E, Franco OL, Hancock RE. Synthetic antibiofilm peptides. Biochim Biophys Acta. 2016;1858(5):1061-1069.
14. Anantharaman A, Rizvi MS, Sahal D. Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides. Antimicrob Agents Chemother. 2010;54(5):1693-1699.
15. Desbois AP, Coote PJ. Bactericidal synergy of lysostaphin in combination with antimicrobial peptides. Eur J Clin Microbiol Infect Dis. 2011;30(8):1015-1021.
16. Wu X, Wang Z, Li X, et al. In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method. Antimicrob Agents Chemother. 2014;58(9):5342-5349.
17. Roscia G, Falciani C, Bracci L, Pini A. The development of antimicrobial peptides as new antibacterial drugs. Curr Protein Pept Sci. 2013;14(8):641-649.
18. Hilchie AL, Wuerth K, Hancock RE. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol. 2013;9(12):761-768.
19. JA M. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. In: Garcia LS, editor. Clinical Microbiology Procedures Handbook. 2nd ed. Washington, DC: ASM Press; 2007:1-23.
20. Hauser C, Hirzberger L, Unemo M, Furrer H, Endimiani A. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother. 2015;59(3):1605-1611.
21. Deslouches B, Gonzalez IA, DeAlmeida D, et al. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother. 2007;60(3):669-672.
22. Kim H, Jang JH, Kim SC, Cho JH. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity. J Antimicrob Chemother. 2014;69(1):121-132.
23. Scott MG, Dullaghan E, Mookherjee N, et al. An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol. 2007;25(4):465-472.
24. Gold HS. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis. 2001;33(2):210-219.
25. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis. 2006;42(suppl 1):S25-S34.
26. Zmantar T, Bekir K, Elgarsadi SI, Hadad O, Bakhrouf A. Molecular investigation of antibiotic resistance genes in methicillin resistant Staphylococcus aureus isolated from nasal cavity in pediatric service. Afr J Microbiol Res. 2013;7(34):4414-4421.
27. Schmitz FJ, Sadurski R, Kray A, et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother. 2000;45(6):891-894.
28. Yin J, Yu S, Liu X, et al. Prevalence and mechanism of resistance to antimicrobial agents in group G streptococcal isolates from China. Antimicrob Agents Chemother. 2011;55(1):402-404.
29. Ding ZF, Zhang H, Tang W, et al. Methylase genes-mediated erythromycin resistance in Staphylococcus aureus from bovine mastitis in China. Isr J Vet Med. 2012;67(3):170-179.
30. Furuya R, Koga Y, Irie S, et al. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother. 2013;19(6):1218-1220.
31. Barbee LA, Soge OO, Holmes KK, Golden MR. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. J Antimicrob Chemother. 2014;69(6):1572-1578.